904 



SUBJECT INDEX 



Nephrectomy, blood lipids following, 465, 



466 

 Nephritides, blood lipids in, 464, 465 

 Nephroses, blood carotene in, 509 



blood lipids in, 463, 464 

 Neo-a-carotene B, 296 

 Neo-a-carotene U, 297 

 Neo-/3-carotene, digestibility coefficient, 



300 

 Neo-0-carotene B, 296 

 Neo-0-carotene U, 296 

 Neo-y-carotene P, 297 

 Neocryptoxanthin A, 297 

 Neocryptoxanthin U, 297 

 Nephron, fat in, 730 

 Nerve impulses, transmission, 26, 27 

 Nerve tissue, acetylcholine in, 751 

 choline acetylase in, 63 

 lipids in, 743, 761-765 



Wallerian degeneration and, 762, 763 

 lipids in invertebrates, 764, 765 

 Nerves, function of in fat mobilization, 



616-618 

 Nervone, 747 

 Nervonic acid, 386 



effect on adrenal cholesterol, 766 

 in brain sphingomyelin, 746 

 Neuraminic acid, in erythrocytes, 361, 386 



in Tay-Sachs' disease, 701 

 Neurine, 248 



Neutral fat (see also Triglycerides) 

 in blood, 357, 358 

 effect of age, 396-400 

 of anemia, 458 

 of diabetes, 447 

 of nephritis, 464 

 of Niemann-Pick's disease, 701 

 of thyroid, 439, 440 

 factors altering concentration, 396- 



410 

 in various species, 383 

 normal range, 379 

 origin, 393 

 in brain, 759 

 in egg yolk, 811 

 in lung, 787 

 in mitochondria, 605 

 in muscles, 736, 737 



Neutral fat {continued): 

 in nervous tissue, 763 

 in pancreas, 788 

 in sebum, 785 

 in skin, 776, 781 

 Nicotine, as cholinesterase inhibitor, 43 

 Nicotinic acid, as cholinesterase inhibitor, 

 35 

 fatty livers and, 683, 688 

 Niemann-Pick's disease, 699-701 

 Nile blue, as cholinesterase inhibitor, 35 

 Nitrogen, use of, for body fat determina- 

 tion, 565 

 p-Nitrophenyl diethylthiophosphate, as 



cholinesterase inhibitor, 43 

 ra-Nonacosane, 277 

 Nonsaponifiable fraction, 213, 254 



in feces, 347 

 Nonylic acid, absorption rate, 182 

 Novocaine, as cholinesterase inhibitor, 35 

 NSF (see Nonsaponifiable fraction) 

 Nu-1250 (N-p-chlorophenyl-N-methylcar- 

 bamate of m-hydroxyphenyltrimethyl- 

 ammonium bromide), 30 

 cholinesterase inhibitor, 30 

 Nutriacholic acid, 72, 86, 87 

 Nutritional edema, effect of choline in, 669, 

 670 

 liver lipids in, 727 

 Nutritional status, cholinesterase and, 49 

 plasma carotene and, 506, 507 

 vitamin A and, 506, 507 

 Nutritional value of fat, absorption rate 

 and, 178 



O 



Obesity, 623-633 



blood lipids in, 424, 425 

 etiology of, 632 



from gold-thioglucose injections, 630 

 from lowered BMR, 630 

 from ovariectomy, 584, 585 

 from overeating, 624-630 

 from reduced activity, 630, 631 

 hereditary, in mice, 631, 632 

 hypothalamus lesions and, 402, 603, 

 617, 625-630 



